Just a heads up, but last year when AMRN announced the late breaking abstract acceptance the stock price sold off pretty hard.
I used that opportunity to double my position. I felt that the announcement was misunderstood and that topline results would be delayed until the AHA meeting in November when of course the topline data was released less than two weeks later.